NCT04272307

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

CompletedEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2020-05-14Est. Completion: 2021-11-03

Enrollment target: 40 participants

Locations

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis

Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …

Bethesda, United StatesEst. completion Jun 1, 2036

Clostridia Difficile ColitisClostridium; Sepsis

A new medication, Bezlotoxumab, has been approved for treatment of recurrent Clostridium difficile diarrhea by the U.S. …

Columbus, United StatesCompleted May 23, 2022

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.